Information Journal Paper
APA:
CopyKIM, B.H., CHO, K.I., & KIM, S.M.. (2012). IRBESARTAN PREVENTS MYOCARDIAL REMODELING IN EXPERIMENTAL THYROTOXIC CARDIOMYOPATHY. ENDOCRINE JOURNAL, 59(-), 919-929. SID. https://sid.ir/paper/661436/en
Vancouver:
CopyKIM B.H., CHO K.I., KIM S.M.. IRBESARTAN PREVENTS MYOCARDIAL REMODELING IN EXPERIMENTAL THYROTOXIC CARDIOMYOPATHY. ENDOCRINE JOURNAL[Internet]. 2012;59(-):919-929. Available from: https://sid.ir/paper/661436/en
IEEE:
CopyB.H. KIM, K.I. CHO, and S.M. KIM, “IRBESARTAN PREVENTS MYOCARDIAL REMODELING IN EXPERIMENTAL THYROTOXIC CARDIOMYOPATHY,” ENDOCRINE JOURNAL, vol. 59, no. -, pp. 919–929, 2012, [Online]. Available: https://sid.ir/paper/661436/en